262 related articles for article (PubMed ID: 32414170)
1. Characterization of Plasma-Derived Small Extracellular Vesicles Indicates Ongoing Endothelial and Platelet Activation in Patients with Thrombotic Antiphospholipid Syndrome.
Štok U; Blokar E; Lenassi M; Holcar M; Frank-Bertoncelj M; Erman A; Resnik N; Sodin-Šemrl S; Čučnik S; Pirkmajer KP; Ambrožič A; Žigon P
Cells; 2020 May; 9(5):. PubMed ID: 32414170
[TBL] [Abstract][Full Text] [Related]
2. Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS).
Solé C; Royo M; Sandoval S; Moliné T; Cortés-Hernández J
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511365
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Vesicles and Antiphospholipid Syndrome: State-of-the-Art and Future Challenges.
Štok U; Čučnik S; Sodin-Šemrl S; Žigon P
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925261
[TBL] [Abstract][Full Text] [Related]
4. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events.
Levy Y; Shenkman B; Tamarin I; Pauzner R; Shoenfeld Y; Langevitz P; Savion N; Varon D
Arthritis Rheum; 2005 Dec; 52(12):4011-7. PubMed ID: 16320349
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles in the Antiphospholipid Syndrome.
Chaturvedi S; Alluri R; McCrae KR
Semin Thromb Hemost; 2018 Jul; 44(5):493-504. PubMed ID: 28476065
[TBL] [Abstract][Full Text] [Related]
6. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
7. Is there a link between mean platelet volume and thrombotic events in antiphospholipid syndrome?
Korkmaz S; Uslu AU; Sahin S; Senel S; Sencan M
Platelets; 2014; 25(5):343-7. PubMed ID: 23971949
[TBL] [Abstract][Full Text] [Related]
8. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
Pierangeli SS; Harris EN
Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
[TBL] [Abstract][Full Text] [Related]
9. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome.
Dignat-George F; Camoin-Jau L; Sabatier F; Arnoux D; Anfosso F; Bardin N; Veit V; Combes V; Gentile S; Moal V; Sanmarco M; Sampol J
Thromb Haemost; 2004 Apr; 91(4):667-73. PubMed ID: 15045126
[TBL] [Abstract][Full Text] [Related]
10. Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome.
Álvarez D; Morales-Prieto DM; Cadavid ÁP
Autoimmun Rev; 2023 Apr; 22(4):103274. PubMed ID: 36649876
[TBL] [Abstract][Full Text] [Related]
11. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
Kato M; Hisada R; Atsumi T
Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
[TBL] [Abstract][Full Text] [Related]
13. The class I phosphoinositide 3-kinases α and β control antiphospholipid antibodies-induced platelet activation.
Terrisse AD; Laurent PA; Garcia C; Gratacap MP; Vanhaesebroeck B; Sié P; Payrastre B
Thromb Haemost; 2016 Jun; 115(6):1138-46. PubMed ID: 26818901
[TBL] [Abstract][Full Text] [Related]
14. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
[TBL] [Abstract][Full Text] [Related]
15. The relationship between mean platelet volume and thrombosis recurrence in patients diagnosed with antiphospholipid syndrome.
Rupa-Matysek J; Gil L; Wojtasińska E; Ciepłuch K; Lewandowska M; Komarnicki M
Rheumatol Int; 2014 Nov; 34(11):1599-605. PubMed ID: 24671503
[TBL] [Abstract][Full Text] [Related]
16. Development of a thrombin generation test in cultured endothelial cells: Evaluation of the prothrombotic effects of antiphospholipid antibodies.
Billoir P; Miranda S; Damian L; Richard V; Benhamou Y; Le Cam Duchez V
Thromb Res; 2018 Sep; 169():87-92. PubMed ID: 30031291
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome - an update.
Linnemann B
Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
[TBL] [Abstract][Full Text] [Related]
19. A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies.
Niccolai E; Squatrito D; Emmi G; Silvestri E; Emmi L; Ciucciarelli L; Ricci F; Manganaro D; Amedei A; Prisco D
Thromb Res; 2015 Dec; 136(6):1252-8. PubMed ID: 26476741
[TBL] [Abstract][Full Text] [Related]
20. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications.
Willemze R; Bradford RL; Mooberry MJ; Roubey RA; Key NS
Thromb Res; 2014 Feb; 133(2):187-9. PubMed ID: 24332063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
